MXPA04008669A - Compuestos azaspiro para el tratamiento de dolores. - Google Patents
Compuestos azaspiro para el tratamiento de dolores.Info
- Publication number
- MXPA04008669A MXPA04008669A MXPA04008669A MXPA04008669A MXPA04008669A MX PA04008669 A MXPA04008669 A MX PA04008669A MX PA04008669 A MXPA04008669 A MX PA04008669A MX PA04008669 A MXPA04008669 A MX PA04008669A MX PA04008669 A MXPA04008669 A MX PA04008669A
- Authority
- MX
- Mexico
- Prior art keywords
- pain
- treatment
- azaspiro compounds
- azaspiro
- compounds
- Prior art date
Links
- 150000008627 azaspiro compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- RBRHMJWQHKXACY-UHFFFAOYSA-N 2-azaspiro[4.6]undecane-3-thione Chemical compound C1NC(=S)CC21CCCCCC2 RBRHMJWQHKXACY-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/54—Spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10210190A DE10210190A1 (de) | 2002-03-07 | 2002-03-07 | Aza-Spiroverbindungen |
| PCT/EP2003/001986 WO2003074486A1 (de) | 2002-03-07 | 2003-02-27 | Aza-spiroverbindungen zur behandlug von schmerzen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04008669A true MXPA04008669A (es) | 2004-12-06 |
Family
ID=27771112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04008669A MXPA04008669A (es) | 2002-03-07 | 2003-02-27 | Compuestos azaspiro para el tratamiento de dolores. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20050288351A1 (enExample) |
| EP (2) | EP1520854A3 (enExample) |
| JP (1) | JP2005526745A (enExample) |
| KR (1) | KR20040091638A (enExample) |
| CN (1) | CN1324011C (enExample) |
| AT (1) | ATE298745T1 (enExample) |
| AU (1) | AU2003215603A1 (enExample) |
| BR (1) | BR0307922A (enExample) |
| CA (1) | CA2477124A1 (enExample) |
| DE (2) | DE10210190A1 (enExample) |
| ES (1) | ES2242944T3 (enExample) |
| MX (1) | MXPA04008669A (enExample) |
| NO (1) | NO20044239L (enExample) |
| PL (1) | PL372431A1 (enExample) |
| PT (1) | PT1485352E (enExample) |
| RU (1) | RU2322438C2 (enExample) |
| UA (1) | UA78987C2 (enExample) |
| WO (1) | WO2003074486A1 (enExample) |
| ZA (1) | ZA200406245B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201607923A (zh) * | 2014-07-15 | 2016-03-01 | 歌林達有限公司 | 被取代之氮螺環（４．５）癸烷衍生物 |
| CN107216335B (zh) * | 2017-06-29 | 2019-04-30 | 上海药明康德新药开发有限公司 | 一种叔丁基1-(羟甲基)-3-氧杂-9-氮杂螺[5.5]十一烷-9-甲酸基酯制法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2866734A (en) * | 1956-12-05 | 1958-12-30 | Us Vitamin Corp | 3-pyridylethyl 2, 4-oxazolidinediones and process |
| US3150143A (en) * | 1960-07-19 | 1964-09-22 | Geschicketer Fund For Medical | Therapeutically active nu-substituted azaspiranes |
| US3398151A (en) * | 1966-02-01 | 1968-08-20 | Mead Johnson & Co | Azaspirodecanediones and azaspiroundecanediones |
| US3629276A (en) * | 1969-07-16 | 1971-12-21 | Abbott Lab | 2-amino-5-spiro-substituted-oxazo compounds |
| US4430335A (en) * | 1983-02-09 | 1984-02-07 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 1-azaspiro[4,5]decanes and their analgesic compositions |
| GB8916447D0 (en) * | 1989-07-19 | 1989-09-06 | Ici Plc | Composition,process and use |
| US5319135A (en) * | 1989-08-25 | 1994-06-07 | Warner-Lambert Company | Process for cyclic amino acid anticonvulsant compounds |
| US5132451A (en) * | 1989-08-25 | 1992-07-21 | Warner-Lambert Company | Process for cyclic amino acid anticonvulsant compounds |
| RU95114363A (ru) * | 1992-11-09 | 1997-03-20 | Дзе Бутс Компани ПЛС. (GB) | Производные азаспиросоединений, способ их получения, фармацевтическая композиция, средства для лечения ожирения, средства для лечения аффективных расстройств |
| US5925672A (en) * | 1996-12-06 | 1999-07-20 | Neurosciences Research Foundation, Inc. | Methods of treating mental diseases, inflammation and pain |
| GB9708484D0 (en) * | 1997-04-25 | 1997-06-18 | Merck Sharp & Dohme | Therapeutic agents |
| DE19732928C2 (de) * | 1997-07-31 | 2000-05-18 | Gruenenthal Gmbh | Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel |
| US5948807A (en) * | 1997-09-03 | 1999-09-07 | Regents Of The University Of Minnesota | Spiroindanamines and Spiroindanimides |
| DE19751062A1 (de) * | 1997-11-18 | 1999-07-08 | Univ Ludwigs Albert | An 4-Stellung substituierte 2-Pyrrolidinon-Derivate zur Verringerung des extrazellulären Glutamat-Spiegels |
| JP2002516312A (ja) * | 1998-05-26 | 2002-06-04 | ワーナー−ランバート・カンパニー | カルシウムチャンネルのα２δサブユニットに対する親和性を有する立体配座的に制約されたアミノ酸化合物 |
-
2002
- 2002-03-07 DE DE10210190A patent/DE10210190A1/de not_active Ceased
-
2003
- 2003-02-27 RU RU2004129769/04A patent/RU2322438C2/ru not_active IP Right Cessation
- 2003-02-27 AU AU2003215603A patent/AU2003215603A1/en not_active Abandoned
- 2003-02-27 DE DE50300710T patent/DE50300710D1/de not_active Expired - Fee Related
- 2003-02-27 WO PCT/EP2003/001986 patent/WO2003074486A1/de not_active Ceased
- 2003-02-27 PT PT03743342T patent/PT1485352E/pt unknown
- 2003-02-27 AT AT03743342T patent/ATE298745T1/de not_active IP Right Cessation
- 2003-02-27 JP JP2003572956A patent/JP2005526745A/ja active Pending
- 2003-02-27 KR KR10-2004-7012680A patent/KR20040091638A/ko not_active Ceased
- 2003-02-27 CN CNB038054388A patent/CN1324011C/zh not_active Expired - Fee Related
- 2003-02-27 ES ES03743342T patent/ES2242944T3/es not_active Expired - Lifetime
- 2003-02-27 UA UA20041008091A patent/UA78987C2/uk unknown
- 2003-02-27 CA CA002477124A patent/CA2477124A1/en not_active Abandoned
- 2003-02-27 PL PL03372431A patent/PL372431A1/xx not_active Application Discontinuation
- 2003-02-27 EP EP04029311A patent/EP1520854A3/de not_active Withdrawn
- 2003-02-27 EP EP03743342A patent/EP1485352B1/de not_active Expired - Lifetime
- 2003-02-27 BR BR0307922-8A patent/BR0307922A/pt not_active IP Right Cessation
- 2003-02-27 MX MXPA04008669A patent/MXPA04008669A/es not_active Application Discontinuation
-
2004
- 2004-08-05 ZA ZA200406245A patent/ZA200406245B/xx unknown
- 2004-09-07 US US10/936,134 patent/US20050288351A1/en not_active Abandoned
- 2004-10-06 NO NO20044239A patent/NO20044239L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE10210190A1 (de) | 2003-09-25 |
| CN1639122A (zh) | 2005-07-13 |
| ZA200406245B (en) | 2005-06-13 |
| RU2004129769A (ru) | 2005-07-10 |
| CA2477124A1 (en) | 2003-09-12 |
| EP1520854A2 (de) | 2005-04-06 |
| PT1485352E (pt) | 2005-10-31 |
| UA78987C2 (en) | 2007-05-10 |
| AU2003215603A1 (en) | 2003-09-16 |
| CN1324011C (zh) | 2007-07-04 |
| HK1080468A1 (zh) | 2006-04-28 |
| EP1520854A3 (de) | 2007-02-21 |
| WO2003074486A1 (de) | 2003-09-12 |
| ATE298745T1 (de) | 2005-07-15 |
| NO20044239L (no) | 2004-12-01 |
| EP1485352A1 (de) | 2004-12-15 |
| AU2003215603A2 (en) | 2003-09-16 |
| JP2005526745A (ja) | 2005-09-08 |
| KR20040091638A (ko) | 2004-10-28 |
| PL372431A1 (en) | 2005-07-25 |
| BR0307922A (pt) | 2004-12-21 |
| RU2322438C2 (ru) | 2008-04-20 |
| US20050288351A1 (en) | 2005-12-29 |
| DE50300710D1 (de) | 2005-08-04 |
| ES2242944T3 (es) | 2005-11-16 |
| EP1485352B1 (de) | 2005-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003035009A3 (en) | Treatment of acute myeloid leukemia with indolinone compounds | |
| WO2001027119A3 (de) | Substanzbibliothek enthaltend bicyclische imidazo-5-yl-amine und/oder bicyclische imidazo-3-yl-amine | |
| MY121047A (en) | Bicyclo [2.2.1] heptanes and related compounds | |
| WO2001078711A3 (en) | Pde-v inhibitors for treatment of parkinson's disease | |
| CA2460939A1 (en) | Substituted pyrazolyl compounds for the treatment of inflammation | |
| CA2407100A1 (en) | 1-aroyl-piperidinyl benzamidines | |
| TNSN04113A1 (en) | 3-â-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF | |
| MXPA05006569A (es) | Compuestos que inhiben la proteina cinasa-2 activada por la proteina cinasa activada por el mitogeno. | |
| WO2003032994A3 (de) | 5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren | |
| WO2004110376A3 (en) | Ccr-2 antagonists for treatment of neuropathic pain | |
| WO2005039504A3 (en) | Compounds and methods for treating toll-like receptor 2-related diseases and conditions | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| CA2461567A1 (en) | Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation | |
| WO2002096351A3 (en) | Ultrashort-acting opioids for transdermal application | |
| WO2003037863A3 (de) | Substituierte indole, verfahren zu deren herstellung und deren verwendung zur schmerzbekämpfung | |
| WO2004073615A3 (en) | Deazaflavin compounds and methods of use thereof | |
| WO2004087880A3 (en) | Compounds and their use to treat diabetes and related disorders | |
| WO2003073979A3 (de) | Derivate von aza-spiroverbindungen zur behandlung von schmerzen | |
| MXPA04000446A (es) | 4-aminociclohexanoles sustituidos. | |
| GB0215526D0 (en) | Anticancer compounds | |
| TW200510437A (en) | Phosphinane compound with immunomodulating activity | |
| MXPA04008669A (es) | Compuestos azaspiro para el tratamiento de dolores. | |
| MXPA04000272A (es) | Derivados de 4-aminociclohexanol sustituidos. | |
| AU3308099A (en) | Method for the treatment of pain, including chronic and female specific pain | |
| AU2003283011A1 (en) | Spirocyclopropyl amides and acids and their therapeutic applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |